CLL Global Research Foundation

 

Upcoming Events
  • Home
  • CLL Information
    • Biology
    • Age & Symptoms
    • Diagnosis
    • Immunology
    • Prognostic Factors
    • Treatments
    • Familial CLL
    • Other
  • News & Views
    • Latest News
    • Upcoming Events
    • President’s Corner
    • Newsletters
    • Multimedia
  • Funded Research
    • Individual Grants
    • Alliance Grants
    • Research Success
    • Other Funding
  • Grant Applications
  • About
    • About Us
    • Mission & Objectives
    • Board of Directors
    • Scientific Advisory Board
  • Donate
  • Contact Us

Multimedia

Video Library

Understanding CLL

Ask the Expert: Are Blood Thinners Safe for CLL Patients?

Highlights From the 2017 iwCLL Meeting
William Werda, MD, PhD, Jeff Folloder

“Living Well with CLL” Town Meeting Morning Session
Nicole Lamanna, MD / Philip Thompson, MB, BS / Andrew Schorr

Big Pharma Joins the Patient Engagement Conversation
Andrew Schorr

What Are Monoclonal Antibodies and How Do They Treat CLL?
Zeev Estrov, MD / Michael Keating, MB, BS

CT Scans: How Much Is Too Much?
Lisa Hicks, MD / Carol Preston

Taking Charge of Your Health: Advice From a Hematologist
Robert A. Hromas, MD, FACP / Carol Preston

CLL Defined
Michael Keating, MB, BS / Nicole Lamanna, MD

Treatment

Expanding Treatment Options for CLL: Session One Replay
Michael Keating, MB, BS / Kathryn Kolibaba, MD / Jeff Sharman, MD / Stephen E. Spurgeon, MD / Andrew Schorr

Expanding Treatment Options for CLL: Session Two Replay
Michael Keating, MB, BS / Kathryn Kolibaba, MD / Jeff Sharman, MD / Nora Larson, MSW, CSWA, LICSWA / Andrew Schorr

Advice for Coping With CLL Treatment Side Effects
Michael Keating, MB, BS / Nicole Lamanna, MD / Wenli Liu, MD / Brad Adams / Allen Melancon / Andrew Schorr

Treatment An Update on CAR T-Cell Therapy
Philip Thompson, MB, BS / Andrew Schorr

I’m Exhausted: Is It My CLL?
Philip Thompson, MB, BS / Andrew Schorr

Where Are We Headed With Frontline CLL Treatment Approaches?
John Gribben, MD, DScn, FRCPath, FRCP FMed / Constantine S. Tam, MBBS, MD / Andrew Schorr

The Evolving CLL Treatment Landscape
Richard Furman, MD / Andrew Schorr

What Could a New Drug Approval Mean for CLL Patients?
William Wierda, MD, PhD

Breaking News: Expert Perspective on Venclexta (venetoclax) Approval
Thomas Kipps, MD, PhD

Expert Advice on CLL and Supplements
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Breaking News: Six Idelalisib (Zydelig) Combination Trials Halted
Jeff Sharman, MD

Combining CLL Treatments
John Gribben, MD, DScn, FRCPath, FRCP FMed / Constantine S. Tam, MBBS, MD / Prof. William Wierda

An Expert Panel Discusses Immunotherapy and CLL
John Gribben, MD, DScn, FRCPath, FRCP FMed / Andrew Schorr / Constantine S. Tam, MBBS, MD / William Wierda, MD, PhD

What Are Monoclonal Antibodies and How Do They Treat CLL?
Zeev Estrov, MD / Michael Keating, MB, BS

Emerging Immunotherapy Options for CLL
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Managing and Monitoring CLL Treatment Side Effects
Nicole Lamanna, MD / Jamie Lynn Gibbons, PA

Understanding the Relationship Between Genetic Testing and Targeted Therapy
Michael Keating, MB, BS / Nicole Lamanna, MD

Ask the Expert: Should Genetic Tests Be Repeated?
Michael Keating, MB, BS

Dr. Susan O’Brien: My Reflections on ASH 2015
Susan M. O’Brien, MD, Associate Director for Clinical Sciences, Chao Family Comprehensive Cancer Center

A Review of CLL Chemotherapy Approaches
Michael Keating, MB, BS / Nicole Lamanna, MD

Treating CLL With Immunotherapy: How Is Research Evolving?
Prof. William Wierda / Andrew Schorr

An Expert’s Review of CLL ASH 2015 News
Prof. William Wierda

Combining New and Emerging CLL Treatments
Michael Keating, MB, BS

ASH 2015: Promising Combination Treatment Approaches
Dr. Andrew Zelenetz / Carol Preston

An Expert’s Update on ROR1
Thomas Kipps, MD, PhD / Andrew Schorr

Living Well with CLL

The Benefits of Exercise During CLL Treatment
Nicole Lamanna, MD / Wenli Liu. MD / Michael Keating, MB, BS / Andrew Schorr

Living Well with CLL You Don’t Have to Suffer: Finding Relief for Cancer Pain
David Hui, MD, MSc / Andrew Schorr

What Should CLL Patients Know About Vaccines?
Nicole Lamanna, MD / Andrew Schorr

CLL and Travel: Is It Safe?
Michael Keating, MB, BS

Big Pharma Joins the Patient Engagement Conversation
Andrew Schorr

Breaking the Cancer Silence
Cherry Sloan-Medrano, RN, BSN, CCM, BC, OCN

What Does Living Well With CLL Mean?
Jamie Lynn Gibbons, PA / Jeff Folloder / Andrew Schorr

Expert Advice on CLL and Supplements
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Andrew Schorr’s Video Blog on Community Oncology
Andrew Schorr

Bob Stamp: Putting CLL in the Rearview Mirror
Bob Stamp

Managing and Monitoring CLL Treatment Side Effects
Nicole Lamanna, MD / Jamie Lynn Gibbons, PA

Slideshow Library

View Slideshow Library

LIBRARY

 

Donate to CLL
Join Our Mailing List

CLL: Where We Have Been and Looking to the Future

Renowned CLL experts Dr. Michael Keating and Dr. William Wierda talk with Patient Power Founder Andrew Schorr about the evolution of CLL care and the ways CLL Global Research Foundation is investing in the future.

Watch the interview


CLL GLOBAL RESEARCH FOUNDATION

P.O. Box 301402
Houston, TX 77230

MISSION STATEMENT

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

NEWSLETTER

Join Our Mailing List

Join Us on facebook

f_logo small

Copyright © 2023 CLL Global · Website designed by White Space Web Studio · Log in